Early Insights into the Characteristics of Tralokinumab Patients in a Real-World Setting in the United States

Main Article Content

Raj Chovatiya
Northwestern University Feinberg School of Medicine, Chicago, IL

Sanjeev Balu
LEO Pharma, Madison, NJ

Yestle Kim
LEO Pharma, Madison, NJ

Amanda G. Althoff
OMNY Health, Atlanta, GA

Lawrence Rasouliyan
OMNY Health, Atlanta, GA

Keywords

atopic dermatitis

References

N/A

Article Sidebar

Poster PDF
Published
May 20, 2023
DOI https://doi.org/10.25251/skin.7.supp.205

Article Details

How to Cite
Chovatiya, R., Balu, S., Kim, Y., Althoff, A. G., & Rasouliyan, L. (2023). Early Insights into the Characteristics of Tralokinumab Patients in a Real-World Setting in the United States. SKIN The Journal of Cutaneous Medicine, 7(3), s205. https://doi.org/10.25251/skin.7.supp.205
Issue
Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23
Section
Atopic Dermatitis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.